Seroprevalence and estimation of the impact of SARS-CoV-2 infection in older adults residing in Long-term Care Facilities in Chile

被引:1
作者
Rubilar, Paola [1 ]
Hirmas, Macarena [1 ]
Matute, Isabel [1 ]
Browne, Jorge [2 ]
Little, Cedric [3 ]
Ruz, Gonzalo [3 ]
Aguilera, Ximena [1 ]
Avila, Carlos [4 ]
Vial, Pablo [5 ]
Mackenzie, Tania Gutknecht [6 ]
机构
[1] Clin Alemana Univ Desarrollo, Fac Med, Ctr Epidemiol & Polit Salud, Santiago, Chile
[2] Serv Nacl Adulto Mayor, Santiago, Chile
[3] Univ Adolfo Ibanez, Fac Ingn & Ciencias, Santiago, Chile
[4] Minist Ciencia Tecnol Conocimiento & Innovac, Santiago, Chile
[5] Clin Alemana Univ Desarrollo, Inst Ciencias & Innovac Med ICIM, Fac Med, Santiago, Chile
[6] Fdn Chile, Santiago, Chile
来源
MEDWAVE | 2022年 / 22卷 / 03期
关键词
COVID-19 Serological Testing; Long-Term Care; aged; SARS-CoV-2; CORONAVIRUS DISEASE 2019;
D O I
10.5867/medwave.2022.03.002553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Older adults are at a higher risk of severe illness and death from COVID-19. This vulnerability increases in those who live in long-term care facilities due to overcrowding, greater physical dependence, and contact with health workers. Evidence on the impact of the pandemic on these establishments in low- and middle-income countries has been scant. This study aims to determine the seroprevalence of SARS-CoV-2 in older people residing in long-term care facilities and estimate the impact of infection after the first wave of the pandemic. Methods A cross-sectional design with 2099 residents in three regions of Chile was carried out between September and November 2020. Measurement of antibodies was performed with a rapid test. The impact of SARS-CoV-2 infection was estimated with seropositive residents, those who had a history of positive polymerase chain reaction tests, and those who died from COVID-19. Bivariate analysis with the region, sex, age, history of COVID-19, physical dependence, and serological results were performed. In addition, we performed a correlation analysis between the seroprevalence of the centers by the municipality and the rate of confirmed cases. Results The seroprevalence of SARS-CoV-2 antibodies in the three regions was 14.7% (95% confidence interval: 13.2 to 16.3%), the infection impact was 46.4%, and the fatality rate was 19.6%. A significant correlation was found between the seroprevalence of older adults residing in long-term care facilities and the cumulative incidence by municipalities. Conclusions The seroprevalence of older adults residing in long-term care facilities was higher than the general population. The high impact of infection among this population at the end of the first wave of the COVID-19 pandemic is similar to other countries. The centers' environment is directly related to COVID-19 infection. Morbidity and mortality monitoring systems should be implemented promptly to establish prevention and control measures.
引用
收藏
页数:11
相关论文
共 45 条
  • [1] Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
    Arons, M. M.
    Hatfield, K. M.
    Reddy, S. C.
    Kimball, A.
    James, A.
    Jacobs, J. R.
    Taylor, J.
    Spicer, K.
    Bardossy, A. C.
    Oakley, L. P.
    Tanwar, S.
    Dyal, J. W.
    Harney, J.
    Chisty, Z.
    Bell, J. M.
    Methner, M.
    Paul, P.
    Carlson, C. M.
    McLaughlin, H. P.
    Thornburg, N.
    Tong, S.
    Tamin, A.
    Tao, Y.
    Uehara, A.
    Harcourt, J.
    Clark, S.
    Brostrom-Smith, C.
    Page, L. C.
    Kay, M.
    Lewis, J.
    Montgomery, P.
    Stone, N. D.
    Clark, T. A.
    Honein, M. A.
    Duchin, J. S.
    Jernigan, J. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) : 2081 - 2090
  • [2] Coronavirus Disease 2019 in French Residential Care Facilities: A Nationwide Study
    Belmin, Joel
    Georges, Scarlett
    Franke, Florian
    Daniau, Come
    Cochet, Amandine
    Durand, Cecile
    Noury, Ursula
    Santo, Maria Eugenia Gomes do Espirito
    Fonteneau, Laure
    Pariel, Sylvie
    Lafuente-Lafuente, Carmelo
    Danis, Kostas
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2021, 22 (06) : 1142 - 1145
  • [3] Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
    Bobrovitz, Niklas
    Arora, Rahul Krishan
    Cao, Christian
    Boucher, Emily
    Liu, Michael
    Donnici, Claire
    Yanes-Lane, Mercedes
    Whelan, Mairead
    Perlman-Arrow, Sara
    Chen, Judy
    Rahim, Hannah
    Ilincic, Natasha
    Segal, Mitchell
    Duarte, Nathan
    Van Wyk, Jordan
    Yan, Tingting
    Atmaja, Austin
    Rocco, Simona
    Joseph, Abel
    Penny, Lucas
    Clifton, David A.
    Williamson, Tyler
    Yansouni, Cedric P.
    Evans, Timothy Grant
    Chevrier, Jonathan
    Papenburg, Jesse
    Cheng, Matthew P.
    [J]. PLOS ONE, 2021, 16 (06):
  • [4] Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
    Bonafede, Machaon M.
    Kalsekar, Anupama
    Pawaskar, Manjiri
    Ruiz, Kimberly M.
    Torres, Amelito M.
    Kelly, Karen R.
    Curkendall, Suellen M.
    [J]. BMC ENDOCRINE DISORDERS, 2011, 11
  • [5] Byrd W., 2020, Journal of Long-term Care, P423, DOI [10.31389/jltc.97, DOI 10.31389/JLTC.97]
  • [6] Carrillo J.A., 2020, PROT CENTR RES PERS, V43, P8
  • [7] Centers for Disease Control and Prevention (CDC), RESP COR COVID 19 NU
  • [8] Chidambaram P, 2021, COVID 19 CASES DEATH
  • [9] de Barros ENC, 2021, REV INST MED TROP SP, V63, DOI [10.1590/s1678-9946202163010, 10.1590/S1678-9946202163010]
  • [10] Denis M., 2020, Transdisciplinary Insights, V4, P1, DOI DOI 10.11116/TDI2020.4.10.SI.COVIPENDIUM